Lawmakers Press For Pricing Info From Teva, Mylan, Heritage

Law360 (August 14, 2019, 7:53 PM EDT) -- Presidential hopeful Sen. Bernie Sanders, I-Vt., and Rep. Elijah E. Cummings, D-Md., announced Wednesday they are looking into whether three drugmakers attempted to obstruct a 2014 investigation over high generics prices, saying that the companies had apparently tried to “stonewall” the earlier probe.

Cummings, who heads the House Committee on Oversight and Government Reform, and Sanders, who is the Senate Committee on the Budget’s ranking member, announced that they have sent letters to Teva Pharmaceutical Industries Ltd., Mylan NV and Heritage Pharmaceuticals.

The lawmakers said that those letters asked the drugmakers for documents originally sought as part of a 2014 investigation into...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS